Lord, Abbett & Co’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-193,117
| Closed | -$13.1M | – | 922 |
|
|
2017
Q4 | $13.1M | Sell |
193,117
-91,448
| -32% | -$6.22M | 0.04% | 580 |
|
|
2017
Q3 | $23.4M | Sell |
284,565
-294,832
| -51% | -$24.3M | 0.07% | 429 |
|
|
2017
Q2 | $54.2M | Sell |
579,397
-24,760
| -4% | -$2.32M | 0.16% | 193 |
|
|
2017
Q1 | $38.5M | Buy |
604,157
+404,784
| +203% | +$25.8M | 0.12% | 279 |
|
|
2016
Q4 | $8.86M | Buy |
199,373
+69,519
| +54% | +$3.09M | 0.03% | 615 |
|
|
2016
Q3 | $4.68M | Buy |
+129,854
| New | +$4.68M | 0.01% | 748 |
|
|
2015
Q4 | – | Sell |
-233,469
| Closed | -$21.5M | – | 969 |
|
|
2015
Q3 | $21.5M | Sell |
233,469
-580,659
| -71% | -$53.4M | 0.06% | 403 |
|
|
2015
Q2 | $71.5M | Buy |
814,128
+243,048
| +43% | +$21.4M | 0.19% | 152 |
|
|
2015
Q1 | $42.4M | Buy |
571,080
+16,685
| +3% | +$1.24M | 0.11% | 294 |
|
|
2014
Q4 | $31M | Buy |
+554,395
| New | +$31M | 0.08% | 359 |
|
|
2014
Q3 | – | Sell |
-123,153
| Closed | -$5.1M | – | 1054 |
|
|
2014
Q2 | $5.1M | Sell |
123,153
-23,737
| -16% | -$983K | 0.01% | 796 |
|
|
2014
Q1 | $10.2M | Sell |
146,890
-246,769
| -63% | -$17.1M | 0.02% | 628 |
|
|
2013
Q4 | $23.7M | Buy |
393,659
+93,865
| +31% | +$5.66M | 0.05% | 484 |
|
|
2013
Q3 | $18.2M | Sell |
299,794
-29,647
| -9% | -$1.8M | 0.04% | 538 |
|
|
2013
Q2 | $22.1M | Buy |
+329,441
| New | +$22.1M | 0.05% | 485 |
|